GuardianMD

Operations

GuardianMD helps nurses, nurse practitioners, and wellness clinics launch and scale compliant healthcare businesses through physician oversight, telemedicine clearance, and CPOM support.

Services
  • Medical Direction
  • Telemedicine clearance exams
  • CPOM Compliant Structure
Location Nationwide
About

GuardianMD

GuardianMD: Your Partner in Clinical Compliance & Medical Oversight

At GuardianMD, we help wellness and healthcare entrepreneurs launch and scale compliant practices with confidence. From IV therapy and aesthetics to wellness, longevity, and telehealth models, our platform is designed to support clinicians navigating the complex operational and regulatory side of patient care.

We specialize in connecting registered nurses, nurse practitioners, and healthcare businesses with physician medical oversight, collaborative agreements, and telemedicine clearance services tailored to state-specific requirements. Our nationwide network and compliance-first approach help providers operate safely while focusing on delivering exceptional patient experiences.

For practices operating in or expanding into Corporate Practice of Medicine (CPOM) states, GuardianMD also provides guidance and infrastructure support for compliant physician ownership and MSO structures. Our team works alongside experienced healthcare attorneys and compliance professionals to help practices build sustainable, scalable foundations.

More than just a compliance vendor, GuardianMD serves as an operational partner for modern healthcare businesses. Through our technology platform, physician network, and clinical support systems, we simplify the backend complexities of running a compliant medical practice so providers can focus on growth, innovation, and patient outcomes.

Together with Seeds Scientific Research & Performance Institute, we’re proud to support the next generation of wellness professionals through education, clinical infrastructure, and trusted medical oversight solutions.

Network with our partners

Upcoming Events

View Upcoming Events
EVENT
Grand Rounds
December 4 - 5, 2026

Grand Rounds

Coming Soon
RESOURCES

Join us in breaking down the latest research live.

VIEW ALL
ARTICLE
William Seeds, MD
Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
William Seeds, MD Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
Why a Plucked Hair Follicle May Matter to the Future of Regenerative Medicine In this article, I return to a study that I discussed in a July Journal Club post. The study, published in Cells in 2024, investigated whether cells obtained from plucked, cryopreserved human hair follicles could be reprogrammed into induced pluripotent stem cells […]
READ ARTICLE
PODCAST
Redox Revolution
Sep 22, 2026
Ep.78 – Do Peptides Cause Cancer? The Risks, The Myths, And The Evidence
Ep.78 – Do Peptides Cause Cancer? The Risks, The Myths, And The Evidence

In this episode, Dr. Seeds addresses the many misunderstandings related to peptides and cancer.

Cellular Medicine Foundations · Peptides & Protocols
Peptide Therapy Certification 2026
The SSRP Peptide Therapy Certification course gives clinicians, researchers, and other healthcare providers a working method for applying Cellular Medicine principles to patient care through clinical peptide therapy. Across 19 faculty-led lessons, Dr. William Seeds and SSRP faculty, including Siobhan...
19 Lessons
15 hrs 43 min
View Course
VIDEO
Cellular Medicine Mondays
Sep 21, 2026
Ep. 106 - Peptide Support After Transplant: What to Consider First
Preview only
Dissecting Protocols – Episode 106

Peptide Support After Transplant: What to Consider First

Dr. Seeds explores how to protect graft integrity and identify the right cellular targets before considering peptide support in a patient six years post liver transplant.

Preview Only — Become a member for full access
SSRP Institute Sep 14, 2026
In Case You Missed it: FDA Approves Mounjaro (tirzepatide) for CVD
HEADLINE SCIENCE [Sept 14, 2026] – On August 28, 2026, the FDA expanded the indication for Mounjaro (tirzepatide), approving the dual GIP/GLP-1 receptor agonist to reduce the risk of major adverse cardiovascular events—including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke—in adults with type 2 diabetes at high cardiovascular risk. The decision makes tirzepatide the […]
READ NEWS
EVENT
Certification
September 10 - 11, 2027
Peptide Therapy Certification 2027
Four Seasons Resort Orlando at Walt Disney World, FL
COMING SOON
Certification
Peptide Therapy Certification 2027
COMING SOON
EVENT
World Congress
June 17 - 19, 2027
Peptide World Congress 2027
Arizona Biltmore, Phoenix, AZ
COMING SOON
World Congress
Peptide World Congress 2027
COMING SOON
EVENT
Mastermind
February 15 - 19, 2027
Fellowship Mastermind Summit 2027
Gansevoort Meatpacking NYC, New York, NY
COMING SOON
Mastermind
Fellowship Mastermind Summit 2027
COMING SOON
EVENT
Grand Rounds
December 4 - 5, 2026
Grand Rounds
Four Seasons Resort and Residences Vail
COMING SOON
Grand Rounds
Grand Rounds
COMING SOON
SSRP Institute Aug 27, 2026
Rasonque: An FDA-Approved Drug to Treat Pancreatic Cancer
HEADLINE SCIENCE [August 27, 2026] – The Food and Drug Administration on Wednesday approved daraxonrasib, sold as Rasonque, for adults with metastatic pancreatic adenocarcinoma, the most common form of pancreatic cancer and one long considered among the hardest to treat. The once-daily tablet, developed by Revolution Medicines, is the first targeted therapy approved for the […]
READ NEWS
SSRP Institute Aug 21, 2026
Alpha-Gal Syndrome: An Update on Incidence Rate by the CDC
HEADLINE SCIENCE [August 21, 2026] – JAMA recently published a report about the incidence rate of alpha-gal syndrome, which is a serious allergic reaction to a sugar molecule called alpha-gal, which is found in most mammals. It is typically transmitted through a bite from a Lone Star tick or other tick species that injects the […]
READ NEWS
IntellxxDNA Aug 12, 2026
SSRP Institute Welcomes IntellxxDNA as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [August 12, 2026] — The SSRP Institute welcomes IntellxxDNA to its Trusted Partner Network following a nomination and internal vetting process, aligning with SSRP’s mission to advance science-first, education-driven clinical collaboration. IntellxxDNA provides clinicians with a structured genomic decision support platform that translates complex genetic data into clinically actionable insights. Using […]
READ NEWS